We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
140 hedge funds and large institutions have $1.2B invested in Madrigal Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
18% more capital invested
Capital invested by funds: $1.01B → $1.2B (+$185M)
1.77% more ownership
Funds ownership: 69.92% → 71.69% (+1.8%)
2% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 46
3% less funds holding
Funds holding: 144 → 140 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
41% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $15.7M
Holders
140
Holders Change
-4
Holders Change %
-2.78%
% of All Funds
2.21%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
21
Increased
45
Reduced
46
Closed
25
Calls
$9.34M
Puts
$15.7M
Net Calls
-$6.39M
Net Calls Change
-$7.6M
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$28.9M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$24.1M |
| 3 |
PA
Perceptive Advisors
New York
|
+$16.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.79M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$35.4M |
| 2 |
AC
Armistice Capital
New York
|
-$12.3M |
| 3 |
Goldman Sachs
New York
|
-$4.8M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.46M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.03M |
